The latest Zach Cregger‑directed horror sequel has amassed $126.5 million worldwide, leaving a slim $3 million gap to crack the franchise’s top‑five list.
Zach Cregger’s fresh take on the Resident Evil saga has just completed its first seven days in theatres and the numbers are already telling a compelling story. The film opened on September 18, pulling in a hefty $26 million on its domestic debut day. That strong start helped it cross the $100 million mark worldwide by the end of the opening weekend, securing the number‑one slot at the U.S. Box office and holding that position throughout the week.
By the time Thursday rolled around, collections dipped to $3.3 million – a 26 percent slide from Wednesday’s earnings – a typical dip when new releases hit the market. Still, the cumulative haul for the week settled at $46 million, pushing the worldwide total to $126.5 million.
According to the Koimoi tally, the film now sits just $3 million shy of breaking into the franchise’s top‑five worldwide earners. Currently ranked sixth, it trails the 2023 entry Apocalypse, which sits at $129.3 million. Surpassing that benchmark would also see Resident Evil 2026 overtake Apocalypse’s second‑weekend figures.
While the domestic figures look robust, the overseas performance tells a different tale. The sequel ranks seventh in the franchise’s overseas earnings, making it one of the lower‑performing entries abroad. Trade observers note that despite its strong U.S. Showing, the film’s international draw remains modest compared with earlier installments.
The movie follows a courier, portrayed by Austin Abrams, who finds himself thrust into a deadly outbreak while delivering a mysterious package to a remote medical facility. Alongside Abrams, the cast features Paul Walter Hauser as Carl, Zach Cherry as Dave, Kali Reis as Pauline and a cameo by Johnno Wilson.
Critics have largely praised the film’s blend of classic horror elements with fresh visual flair, and audience scores echo that sentiment. The combination of a recognizable franchise name, a director with a knack for tension, and a cast that balances veteran character actors with rising talent appears to have resonated with American moviegoers.
Looking ahead, the next few days will be crucial. If the film can sustain its current momentum, especially in the U.S., it could close the $3 million gap and secure a spot among the franchise’s elite earners. However, a slowdown in the domestic market or a surge from competing releases could stall that push.
For now, Resident Evil 2026 remains the week’s top grosser in the United States and a strong contender for a historic franchise milestone. Fans of the series will be watching the box‑office trajectory closely, while industry analysts will be dissecting the overseas shortfall to gauge the global appetite for another zombie‑laden adventure.
What’s next? The film continues its theatrical run across North America, with international markets slated for staggered releases over the coming weeks. The coming weekend’s box‑office figures will reveal whether the sequel can finally break into the franchise’s coveted top‑five worldwide.
Stay tuned for updates as the numbers roll in.
Be the first to comment
Join the argument. No password, just your email or a passkey.